Bulltick Wealth Management’s AbbVie ABBV Stock Holding History

Bulltick Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$428K	Sell	1,699 -22	-1%	-$4.73K	0.09%	91
2026 Q1	$374K	Buy	1,721 +7	+0.4%	+$1.55K	0.08%	98
2025 Q4	$392K	Buy	+1,714	New	+$390K	0.08%	90
2022 Q1	–	Sell	-9,557	Closed	-$1.29M	–	137
2021 Q4	$1.29M	Hold	9,557	–	–	0.26%	52
2021 Q3	$1.03M	Buy	9,557 +302	+3%	+$34.5K	0.23%	49
2021 Q2	$1.04M	Buy	+9,255	New	+$1.04M	0.24%	49

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bulltick Wealth Management's ABBV Position: Q2 2026 in Review

Bulltick Wealth Management reduced its AbbVie (ABBV) stake by 1.3% in Q2 2026, selling an estimated $4.73K and leaving 1,699 shares worth $428K. The position accounts for 0.09% of the portfolio, ranked #91.

Bulltick Wealth Management first reported a position in ABBV in Q2 2021 and has held it in 6 quarters since. The position peaked at $1.29M in Q4 2021. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Bulltick Wealth Management held 1,699 shares of AbbVie worth $428K as of Q2 2026.
Bulltick Wealth Management sold 22 AbbVie shares in Q2 2026, an estimated $4.73K.
AbbVie made up 0.09% of Bulltick Wealth Management's portfolio in Q2 2026, its #91 holding.
Bulltick Wealth Management first reported a position in AbbVie in Q2 2021 and has held it in 6 quarters since.
Bulltick Wealth Management's AbbVie position peaked at $1.29M in Q4 2021.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Bulltick Wealth Management's 13F filing for Q2 2026, filed 30 Jul 2026.